BCL2 and prostate carcinoma: Self-delivery of FANA ASOs was previously reported by Souleimanian and colleagues37 using a human prostate cancer cell line, who observed that FANA ASOs effectively silenced the expression of the Bcl-2 protein in the absence of any carriers or conjugation.